Trial Profile
Effects and Safety of Radiofrequency ablation combined withSorafenib in hepatocellular carcinoma(HCC): a pilot study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 22 Jan 2013 New trial record